Promontory Therapeutics is a clinical-stage pharmaceutical company focused on novel therapeutics in oncology.
Promontory Therapeutics has raised $37.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.
Promontory Therapeutics is headquartered in New York, United States.
Promontory Therapeutics is a clinical-stage pharmaceutical company focused on novel therapeutics in oncology.
Promontory Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Promontory Therapeutics — Funding & Investors." VCBacked, December 14, 2021, https://www.vcbacked.co/company/promontory-therapeutics. Accessed August 17, 2026.
VCBacked. (2021). Promontory Therapeutics — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/promontory-therapeutics
{{cite web |title=Promontory Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/promontory-therapeutics |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated